These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1571315)

  • 21. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls.
    Kubistova A; Horacek J; Novak T
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S153-6. PubMed ID: 22945211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.
    Villinger F; Rollin PE; Brar SS; Chikkala NF; Winter J; Sundstrom JB; Zaki SR; Swanepoel R; Ansari AA; Peters CJ
    J Infect Dis; 1999 Feb; 179 Suppl 1():S188-91. PubMed ID: 9988183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased blink rate in drug-naive acute schizophrenic patients.
    Mackert A; Woyth C; Flechtner KM; Volz HP
    Biol Psychiatry; 1990 Jun; 27(11):1197-202. PubMed ID: 2354226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration.
    Akiyama K
    Schizophr Res; 1999 May; 37(1):97-106. PubMed ID: 10227112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration.
    Xiong P; Zeng Y; Wu Q; Han Huang DX; Zainal H; Xu X; Wan J; Xu F; Lu J
    J Clin Psychiatry; 2014 Aug; 75(8):e794-801. PubMed ID: 25191916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological dysfunction in schizophrenia: a systematic approach.
    Rothermundt M; Arolt V; Weitzsch C; Eckhoff D; Kirchner H
    Neuropsychobiology; 1998; 37(4):186-93. PubMed ID: 9648126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders.
    Katila H; Appelberg B; Hurme M; Rimón R
    Schizophr Res; 1994 Apr; 12(1):29-34. PubMed ID: 8018583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of interleukin-4, interferon (IFN)-gamma and IFN-alpha in human immunodeficiency virus-1 infection: an imbalance of type 1 and type 2 cytokines may reduce the synthesis of IFN-alpha.
    Hober D; Benyoucef S; Chehadeh W; Chieux V; De La Tribonniere X; Mouton Y; Bocket L; Wattre P
    Scand J Immunol; 1998 Oct; 48(4):436-42. PubMed ID: 9790316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients.
    Singh B; Bera NK; Nayak CR; Chaudhuri TK
    Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
    Gallo P; Piccinno MG; Pagni S; Argentiero V; Giometto B; Bozza F; Tavolato B
    J Neurol Sci; 1989 Aug; 92(1):9-15. PubMed ID: 2504888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia.
    O'Brien SM; Scully P; Dinan TG
    Psychiatry Res; 2008 Sep; 160(3):256-62. PubMed ID: 18722671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination between and among schizophrenics and other pathologies using a Spanish version of the Whitaker Index of Schizophrenic Thinking.
    Godoy JF; Fernandez M; Muela JA; Roldan G; Catena A; Puente AE
    J Clin Psychol; 1994 Mar; 50(2):158-61. PubMed ID: 8014238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is schizophrenia linked to alteration in cellular immunity?
    Sperner-Unterweger B; Barnas C; Fleischhacker WW; Fuchs D; Meise U; Reibnegger G; Wachter H
    Schizophr Res; 1989; 2(4-5):417-21. PubMed ID: 2487182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia.
    Yang ZW; Chengappa KN; Shurin G; Brar JS; Rabin BS; Gubbi AV; Ganguli R
    Psychol Med; 1994 May; 24(2):449-55. PubMed ID: 8084939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF phenylacetic acid and hostility in paranoid schizophrenia.
    Faull KF; King RJ; Barchas JD; Csernansky JG
    Psychiatry Res; 1989 Nov; 30(2):111-8. PubMed ID: 2616681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
    Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
    Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical attributes of schizophrenic skin conductance responders and non-responders.
    Gruzelier JH
    Psychol Med; 1976 May; 6(2):245-9. PubMed ID: 826921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapy.
    Zhang L; Hao CQ; Miao L; Dou XG
    Genet Mol Res; 2014 Nov; 13(4):9747-55. PubMed ID: 25501184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.